This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
LAVAL, Quebec, July 9, 2013 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("
Neptune") (Nasdaq:NEPT) (TSX:NTB) will be holding a conference call on Tuesday July 16, at 9:00 am ET to present its results for the first quarter ended May 31, 2013. The Company will also be providing an update on the status of its previously disclosed action plan to resume operations and supply customers.
The conference call hosts will be Henri Harland, President & CEO and André Godin, CFO.
To access the conference call within Canada & the U.S., dial toll-free 1‐877-380-5664. Outside Canada and the U.S., dial 1-631-813-4882.
Conference call details:
Neptune Technologies & Bioressources first quarter ended May 31, 2013 Results Call
9:00 AM Eastern Time
Management will accept questions related to the financial results and its operations by telephone during the Q&A period at the end of the presentation. Questions can also be forwarded in advance or during the presentation to
An archived recording of the conference call will be available on Neptune's website (
www.neptunebiotech.com ) shortly after the call.
Neptune's audited consolidated financial statements for the quarter ended May 31, 2013 and related MD&A will be made available on SEDAR at
www.sedar.com , on EDGAR at
www.sec.gov/edgar.shtml and on Neptune's website at
http://www.neptunebiotech.com prior to the conference call.
About Neptune Technologies & Bioressources Inc.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids (''PUFAs''). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune's distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune's products generally come in capsule form and serve as a dietary supplement to consumers.